This inventor holds 3 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1999
Title: Yasushi Taniguchi: Innovator in Monoclonal Antibody Technology
Introduction
Yasushi Taniguchi is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. With a total of 3 patents to his name, Taniguchi's work has the potential to impact various medical applications.
Latest Patents
Taniguchi's latest patents focus on innovative methods for measuring N-peptide using monoclonal antibodies. One of his notable inventions is a sandwich immunoassay that allows for the rapid and efficient measurement of N-peptide. This method involves incubating a sample with a first monoclonal antibody that recognizes a specific portion of the N-peptide. Following this, a labeled second monoclonal antibody is added, which also recognizes a different portion of the N-peptide. The resulting antigen-antibody complex can then be detected, providing valuable information for medical diagnostics.
Another patent by Taniguchi involves the production of hybridoma cells that generate monoclonal antibodies for N-peptide. This invention also utilizes a sandwich immunoassay format, emphasizing the versatility and effectiveness of his approach in measuring N-peptide or its precursors.
Career Highlights
Yasushi Taniguchi is associated with Shionogi Company Limited, where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, contributing to the understanding and application of monoclonal antibodies in clinical settings.
Collaborations
Throughout his career, Taniguchi has collaborated with notable colleagues, including Hidehisa Asada and Keiji Dohi. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective research.
Conclusion
Yasushi Taniguchi's innovative work in the field of monoclonal antibodies showcases his dedication to advancing medical science. His patents reflect a commitment to improving diagnostic methods, which could lead to better patient outcomes in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile